Curaxis Pharmaceutical Corporation Management to Meet With Shareholders bi13281818 RALEIGH, N.C. -- Timothy R. Wright, Chairman and Interim Chief Executive Officer of Curaxis Corporation ("Curaxis" or the "Company') (OTCQB:CURX.PK - News), announced today that the ..

Hikma Pharmaceutical - Interim Management Statement bi13281818 Hikma - Interim Management Statement..

Elite Pharmaceuticals, Inc. to Discuss Second Quarter 2012 Results of Operati bi13281818 NORTHVALE, N.J. -- Elite s, Inc. , a specialty company dedicated to developing and commercializing oral sustained and controlled release product formulations and generics ..

Pharmaceutical Distributors Continue to Deliver Operational Efficiencies and bi13281818 Contact: Farah Qureshi, +1-703-885-0269, fqureshi@hdmanet.org..

K-V Pharmaceutical Announces Updated Makena® Performance Metrics bi13281818 ST. LOUIS, Nov. 8, 2011 /PRNewswire/ -- K-V Company (NYSE: KV.A/ KV.B) (the "Company" or "K-V"), today reported updated performance metrics for Makena®, the only U.S. Food & Drug Administration ("FDA") approved product indicated to reduce the risk of preterm birth..

Are Shorts Watching Pharmaceutical Product Development? bi13281818 Look here for a clue

How pharmaceutical companies can help take the 'neglected' out of neglected t bi13281818 Video What do schistosomiasis, cysticercosis, and lymphatic filariasis have common? Besides verging on the unpronounceable, they are all classified as neglected tropical diseases (NTDs). NTDs are a set of diseases ? seventeen, by the World Health Organization?s count ? that collectively affect over a billion people, but have historically []..

Pharmaceutical Distributors Continue to Deliver Operational Efficiencies and bi13281818 Contact: Farah Qureshi, +1-703-885-0269, fqureshi@hdmanet.org..

Raptor Pharmaceutical Corp. to Present at the Lazard Capital Markets 8th Annu bi13281818 NOVATO, Calif. -- Raptor Corp. ("Raptor" or the "Company") , today announced that Ted Daley, President of Raptor present an overview of the Company at the Lazard ..

Why the Future Looks Bright for Teva Pharmaceutical bi13281818 Don't just ask, "How much inventory?" Ask, "What kind?"..

Pharmaceutical industry should invest more NTDs bi13281818 In Forbes opinion piece, contributor Sarika Bansal examines "what needs to happen for the industry, academic researchers, and other key players to begin investing more seriously in" neglected tropical diseases

Elite Pharmaceuticals, Inc. to Discuss Second Quarter 2012 Results of Operati bi13281818 NORTHVALE, N.J. -- Elite s, Inc. , a specialty company dedicated to developing and commercializing oral sustained and controlled release product formulations and generics ..

Derma Sciences Reports Third Quarter Financial and Operating Results; End-of- bi13281818 PRINCETON, N.J.--(BUSINESS WIRE)--Derma Sciences, Inc. (Nasdaq: DSCI), a medical device and company focused on advanced wound care, today reported financial and operating results for the three and nine months ended September 30, 2011. Highlights of the third quarter of 2011 and recent weeks include: Net sales were $15.8 million, up 5% over the prior-year third quarter Quarterly ..

Tapeware Backup Software - Home